Vignesh Hariharan

413 total citations
9 papers, 120 citations indexed

About

Vignesh Hariharan is a scholar working on Molecular Biology, Epidemiology and Cancer Research. According to data from OpenAlex, Vignesh Hariharan has authored 9 papers receiving a total of 120 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Epidemiology and 2 papers in Cancer Research. Recurrent topics in Vignesh Hariharan's work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and MicroRNA in disease regulation (2 papers). Vignesh Hariharan is often cited by papers focused on RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers) and MicroRNA in disease regulation (2 papers). Vignesh Hariharan collaborates with scholars based in United States, Canada and Netherlands. Vignesh Hariharan's co-authors include Nicholas McHugh, Annabelle Biscans, Anastasia Khvorova, Manish Muhuri, Dimas Echeverria, S. Ananth Karumanchi, Agnes S. Lo, Melissa J. Moore, Sarah M. Davis and Anton A. Turanov and has published in prestigious journals such as Nucleic Acids Research, The FASEB Journal and Molecular Therapy.

In The Last Decade

Vignesh Hariharan

8 papers receiving 118 citations

Peers

Vignesh Hariharan
Zachary R. Weiss United States
Chen Cao China
Amy C. Seila White United States
Alicia Branch United States
Vignesh Hariharan
Citations per year, relative to Vignesh Hariharan Vignesh Hariharan (= 1×) peers Marlene Jentzsch

Countries citing papers authored by Vignesh Hariharan

Since Specialization
Citations

This map shows the geographic impact of Vignesh Hariharan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vignesh Hariharan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vignesh Hariharan more than expected).

Fields of papers citing papers by Vignesh Hariharan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vignesh Hariharan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vignesh Hariharan. The network helps show where Vignesh Hariharan may publish in the future.

Co-authorship network of co-authors of Vignesh Hariharan

This figure shows the co-authorship network connecting the top 25 collaborators of Vignesh Hariharan. A scholar is included among the top collaborators of Vignesh Hariharan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vignesh Hariharan. Vignesh Hariharan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
O’Reilly, Daniel, et al.. (2025). Systematic Evaluation of Position-Specific Tolerability of Seven Backbone and Ribose Modifications in Fully Chemically Stabilized siRNAs. Nucleic Acid Therapeutics. 35(3). 137–149. 1 indexed citations
2.
Hariharan, Vignesh, et al.. (2024). Phosphatidylcholine head group chemistry alters the extrahepatic accumulation of lipid-conjugated siRNA. Molecular Therapy — Nucleic Acids. 35(2). 102230–102230. 2 indexed citations
3.
Ferguson, Chantal, Bruno M.D.C. Godinho, Dimas Echeverria, et al.. (2024). A combinatorial approach for achieving CNS-selective RNAi. Nucleic Acids Research. 52(9). 5273–5284. 3 indexed citations
4.
O’Reilly, Daniel, David van de Vijver, Ingrid E.C. Verhaart, et al.. (2023). Challenges of Assessing Exon 53 Skipping of the Human DMD Transcript with Locked Nucleic Acid-Modified Antisense Oligonucleotides in a Mouse Model for Duchenne Muscular Dystrophy. Nucleic Acid Therapeutics. 33(6). 348–360. 7 indexed citations
5.
Liu, Xuejun, Jenny Jiang, Danshi Li, et al.. (2023). Antiplatelet Treatment Patterns and Outcomes for Secondary Stroke Prevention in the United Kingdom. Cardiology and Therapy. 12(4). 675–687. 2 indexed citations
6.
Fakih, Hassan H., Qi Tang, Ashley Summers, et al.. (2023). Dendritic amphiphilic siRNA: Selective albumin binding, in vivo efficacy, and low toxicity. Molecular Therapy — Nucleic Acids. 34. 102080–102080. 8 indexed citations
7.
Davis, Sarah M., Vignesh Hariharan, Agnes S. Lo, et al.. (2022). Chemical optimization of siRNA for safe and efficient silencing of placental sFLT1. Molecular Therapy — Nucleic Acids. 29. 135–149. 36 indexed citations
8.
Hariharan, Vignesh, Chandrani Thakur, Albel Singh, et al.. (2021). Cyclic di‐GMP sensing histidine kinase PdtaS controls mycobacterial adaptation to carbon sources. The FASEB Journal. 35(4). e21475–e21475. 15 indexed citations
9.
Biscans, Annabelle, et al.. (2020). Docosanoic acid conjugation to siRNA enables functional and safe delivery to skeletal and cardiac muscles. Molecular Therapy. 29(4). 1382–1394. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026